Takao Honda

Takao Honda is a highly accomplished professional with a strong background in the pharmaceutical industry, currently serving as the Senior Director at Lilly New Ventures, Asia within Eli Lilly and Company.

Takao Honda pursued his education at Osaka University, where he focused on organic synthesis chemistry at the graduate level.

Prior to his current role, Takao Honda held various key positions within Eli Lilly and Company, including Director of Emerging Technologies and Innovation. He also served as Senior Manager for External Innovation in Japan and on a global scale within the company.

Before joining Eli Lilly, Takao Honda gained valuable experience as a Senior Manager at Mitsubishi Tanabe Pharma Corporation and as a Licensing Manager in London at Tanabe Seiyaku Co LTD.

Takao Honda's extensive expertise in external innovation, licensing, and global R&D strategy makes him a respected figure in the pharmaceutical sector, especially in the Asian market.